Seeds Investor’s NYLIM Candriam U.S. Mid Cap Equity ETF IQSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Sell
46,325
-6,740
-13% -$254K 0.19% 108
2026
Q1
$1.94M Sell
53,065
-46,203
-47% -$1.66M 0.26% 73
2025
Q4
$3.44M Sell
99,268
-16,665
-14% -$571K 0.66% 36
2025
Q3
$3.93M Buy
115,933
+38,923
+51% +$1.3M 0.83% 28
2025
Q2
$2.48M Buy
77,010
+27,575
+56% +$846K 0.58% 37
2025
Q1
$1.51M Buy
49,435
+4,950
+11% +$161K 0.42% 39
2024
Q4
$1.44M Buy
44,485
+2,547
+6% +$85.6K 0.41% 36
2024
Q3
$1.38M Buy
41,938
+1,671
+4% +$52.5K 0.52% 27
2024
Q2
$1.22M Buy
40,267
+13,327
+49% +$408K 0.63% 27
2024
Q1
$871K Buy
26,940
+7,208
+37% +$220K 0.8% 27
2023
Q4
$594K Buy
+19,732
New +$536K 0.67% 42

Other funds holding IQSM

Seeds Investor's IQSM Position: Q2 2026 in Review

Seeds Investor reduced its NYLIM Candriam U.S. Mid Cap Equity ETF (IQSM) stake by 13% in Q2 2026, selling an estimated $254K and leaving 46,325 shares worth $1.84M. The position accounts for 0.19% of the portfolio, ranked #108.

Seeds Investor first reported a position in IQSM in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.93M in Q3 2025. 7 funds tracked by Wall St. Rank hold IQSM as of Q2 2026.

  • Seeds Investor held 46,325 shares of NYLIM Candriam U.S. Mid Cap Equity ETF worth $1.84M as of Q2 2026.
  • Seeds Investor sold 6,740 NYLIM Candriam U.S. Mid Cap Equity ETF shares in Q2 2026, an estimated $254K.
  • NYLIM Candriam U.S. Mid Cap Equity ETF made up 0.19% of Seeds Investor's portfolio in Q2 2026, its #108 holding.
  • Seeds Investor first reported a position in NYLIM Candriam U.S. Mid Cap Equity ETF in Q4 2023 and has held it in 11 quarters since.
  • Seeds Investor's NYLIM Candriam U.S. Mid Cap Equity ETF position peaked at $3.93M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held NYLIM Candriam U.S. Mid Cap Equity ETF as of Q2 2026.

Based on Seeds Investor's 13F filing for Q2 2026, filed 12 Aug 2026.